{"count": 2, "results": [{"_id": "1418836", "pmid": 1418836, "title": "A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension.", "journal": "Am J Hypertens", "authors": ["Johnson BF", "Frishman WH", "Brobyn R", "Brown RD", "Reeves RL", "Wombolt DG"], "date": "1992-10-01T00:00:00Z", "doi": "10.1093/ajh/5.10.727", "meta_date_publication": "1992 Oct", "meta_volume": "5", "meta_issue": "10", "meta_pages": "727-32", "score": 50052.645, "text_hl": "Heart rate was significantly lowered by @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ only. Both @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ were well-tolerated. ", "citations": {"NLM": "Johnson BF, Frishman WH, Brobyn R, Brown RD, Reeves RL, Wombolt DG. A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension. Am J Hypertens. 1992 Oct;5(10):727-32. PMID: 1418836", "BibTeX": "@article{1418836, title={A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension.}, author={Johnson BF and Frishman WH and Brobyn R and Brown RD and Reeves RL and Wombolt DG}, journal={Am J Hypertens}, volume={5}, number={10}, pages={727-32}}"}}, {"_id": "22251015", "pmid": 22251015, "title": "Fasitibant chloride, a kinin B2 receptor antagonist, and dexamethasone interact to inhibit carrageenan-induced inflammatory arthritis in rats.", "journal": "Br J Pharmacol", "authors": ["Valenti C", "Giuliani S", "Cialdai C", "Tramontana M", "Maggi CA"], "date": "2012-06-01T00:00:00Z", "doi": "10.1111/j.1476-5381.2012.01861.x", "meta_date_publication": "2012 Jun", "meta_volume": "166", "meta_issue": "4", "meta_pages": "1403-10", "score": 50049.76, "text_hl": "A combination of drugs inhibiting @<m>DISEASE_Arthralgia</m> @DISEASE_MESH:D018771 @@@joint pain@@@ (fasitibant chloride, des-Arg9-[Leu8]-bradykinin, @CHEMICAL_dexketoprofen_trometamol @CHEMICAL_MESH:C118296 @@@dexketoprofen@@@, @CHEMICAL_verlukast @CHEMICAL_MESH:C059141 @@@MK571@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@) and @DISEASE_Tang_Hsi_Ryu_syndrome @DISEASE_MESH:C536897 @@@oedema@@@ (fasitibant chloride, des-Arg9-[Leu8]-bradykinin, @CHEMICAL_verlukast @CHEMICAL_MESH:C059141 @@@MK571@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@) abolished the respective @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ response, producing inhibition comparable with that achieved with the combination of fasitibant chloride and @CHEMICAL_Dexamethasone @CHEMICAL_MESH:D003907 @@@dexamethasone@@@. ", "citations": {"NLM": "Valenti C, Giuliani S, Cialdai C, Tramontana M, Maggi CA. Fasitibant chloride, a kinin B2 receptor antagonist, and dexamethasone interact to inhibit carrageenan-induced inflammatory arthritis in rats. Br J Pharmacol. 2012 Jun;166(4):1403-10. PMID: 22251015", "BibTeX": "@article{22251015, title={Fasitibant chloride, a kinin B2 receptor antagonist, and dexamethasone interact to inhibit carrageenan-induced inflammatory arthritis in rats.}, author={Valenti C and Giuliani S and Cialdai C and Tramontana M and Maggi CA}, journal={Br J Pharmacol}, volume={166}, number={4}, pages={1403-10}}"}}]}